Difference between revisions of "Part:BBa K5013003"

Revision as of 09:56, 12 October 2023

This is a phenylalanine degrading enzyme controlled by a hypoxic promoter

Considering the functionality of phenylalanine lyase (PAL) in an anaerobic environment, we decided to position PAL downstream of the hypoxia promoter (pPepT), as this part allows for the regulation of PAL expression in such conditions. Ultimately, this composite part facilitates the transformation of phenylalanine into trans-cinnamic acid.

Usage and Biology

Firtly, we express the pal gene by utilizing the pLac and the ribosome binding site B0034. The pET23b vector will be employed, and the engineered plasmid will be introduced into E.coli Rosetta for efficient expression.

Figure 1 The design of gene circuit for PAL overexpression.

Figure 2 Gel electrophoresis of the pal gene.

By measuring the Phe content and TCA content after expressing the engineered strains, the degradation ability of PAL was evaluated. The strains were resuspended in 1 mL of Phe experimental buffer (M9 0.5% glucose with 1 mM Phe) to an OD600 of 0.1, and the Phe content was determined using a phenylalanine ELISA kit.

Based on the Phe content measurement experiment, we used an microplate reader reader to measure OD290 and calculate the concentration of TCA. The results are shown in Figure 3. After expressing PAL, the Phe content decreased while the TCA content significantly increased, indicating that PAL can effectively degrade Phe into TCA.

Figure 3 PAL degradation capability.

Additionally, we also validated the effect of environmental pH on the metabolic capacity of PAL. As shown in Figure 4, when the environmental pH value ranged from 5 to 8, the content of TCA increased with the increase in pH value. Therefore, this experiment can demonstrate that within the pH range of 5 to 8, the activity of PAL increases with the increase in pH value, with pH 8 being the optimal pH.

Figure 4 Testing the impact of pH environment on the degradation ability of PAL. .

After them, we used a hypoxia-sensing promoter (pPepT), constructed phenylalanine lyase (PAL) gene downstream of it, and used B0015 as gene circuit terminator. The constructed plasmid based on pSB1A3 was then introduced into E. coli BL21.

Figure 5 Design of pPepT and PAL.

Characterization

We tested the expression of the anaerobic promoter, as shown in Figure 6A, and found that it was expressed normally under anaerobic conditions. By measuring the Phe content and TCA content after expressing the engineered strains, the degradation ability of PAL was evaluated. The strains were resuspended in 1 mL of Phe experimental buffer (M9 0.5% glucose with 1 mM Phe) to an OD600 of 0.1, and the Phe content was determined using a phenylalanine ELISA kit. Based on the Phe content measurement experiment, we used an microplate reader reader to measure OD290 and calculate the concentration of TCA. We measured the levels of Phe and TCA, as shown in Figures 6B and 6C. We observed higher TCA production under lower oxygen concentrations, indicating that PAL can play a significant role under anaerobic conditions. Furthermore, we validated the effect of environmental pH on PAL metabolic capacity, as shown in Figure 6D. PAL activity increased with increasing pH within the range of pH 5 to 8, with pH 8 being the optimal pH.

Figure 6 Expression data graph of the hypoxic promoter.

Potential application directions

This experiment demonstrated the efficacy of pPepT-PAL in regulating PAL expression in an anaerobic environment. This finding has potential applications in future probiotic production, as it addresses the issue of nutritional depletion caused by protein expression during bacterial cultivation and storage. By extending the growth cycle and reducing shelf-life, probiotic bacteria can now effectively express relevant proteins in the anaerobic intestinal environment. This not only lowers production costs but also enhances patient efficacy. Therefore, this research holds promising development prospects.

References

Chien, Tiffany, et al. "Enhancing the tropism of bacteria via genetically programmed biosensors." Nature biomedical engineering 6.1 (2022): 94-104. Isabella, Vincent M., et al. "Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria." Nature biotechnology 36.9 (2018): 857-864.

Sequence and Features